The client diagnosed with Parkinson's Disease (PD) is being admitted with a fever and patchy infiltrates in the lung fields on the chest x-ray. Which clinical manifestations of PD would explain this assessment data?

A) Insertion of a cardioverter-defibrillator:
Hypertrophic cardiomyopathy (HCM) is a condition characterized by abnormal thickening of the heart muscle, particularly the septum, which can lead to obstruction of blood flow and contribute to the development of arrhythmias. The most concerning arrhythmias in HCM include ventricular tachycardia and ventricular fibrillation, both of which can lead to sudden cardiac arrest. A cardioverter-defibrillator (ICD) is a device that monitors the heart's rhythm and can deliver a shock to restore normal rhythm in the event of a life-threatening arrhythmia.

B) A medication regimen that includes nitrates:
Nitrates are vasodilators commonly used in the treatment of conditions like angina and heart failure. However, nitrates are generally avoided in patients with hypertrophic cardiomyopathy because they can exacerbate the condition by decreasing preload and increasing the outflow tract obstruction due to the thickened heart muscle.

C) Immediate cardiac transplantation:
Cardiac transplantation is a treatment for end-stage heart failure, typically in patients who have not responded to medical or surgical treatments. While hypertrophic cardiomyopathy can lead to heart failure, it is not the first line treatment for dysrhythmias or complications from the disease.

D) Insertion of a drug-eluting stent:
Drug-eluting stents are used to prevent restenosis (narrowing) of coronary arteries after percutaneous coronary intervention (PCI) in patients with coronary artery disease (CAD). However, hypertrophic cardiomyopathy is not caused by coronary artery disease.

A) 3% Normal Saline:
Elevated ICP can lead to a life-threatening condition known as cerebral herniation, and it often triggers the Cushing’s triad—widened pulse pressure, bradycardia, and irregular respirations, all of which the nurse has noted. Hypertonic saline (such as 3% Normal Saline) is commonly used to manage increased ICP because it creates an osmotic gradient that draws fluid out of the brain tissue, reducing cerebral edema and lowering ICP. The goal is to reduce swelling and prevent further brain damage.

B) Nitroprusside:
Nitroprusside is a potent vasodilator that is used to treat hypertension and reduce afterload in conditions like heart failure or aortic dissection. However, in this case, nitroprusside is contraindicated because it could cause a drop in systemic blood pressure, which would worsen cerebral perfusion in a patient with elevated ICP.

C) Norepinephrine:
Norepinephrine is a vasopressor used to treat hypotension by increasing systemic vascular resistance and blood pressure. Although norepinephrine may be used to support blood pressure in critically ill patients, in this context of elevated ICP, the priority is to reduce ICP, not to increase blood pressure further. Increasing the systemic vascular resistance with norepinephrine could exacerbate ICP by increasing the volume of blood in the cranium

D) Furosemide:
Furosemide is a loop diuretic that can reduce fluid volume and help treat conditions like edema or heart failure. While furosemide can reduce overall fluid volume, it is not typically used to manage elevated ICP in this context. Diuretics like furosemide may have a role in managing cerebral edema, but they are not as effective as hypertonic saline in rapidly reducing ICP.